These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 630884)

  • 41. [Action of prostaglandin F2 alpha on lst-trimester pregnancy].
    Talas M; Gecko P; Fingerová G; Hamal Z
    Akush Ginekol (Mosk); 1981 Nov; (11):52. PubMed ID: 6948529
    [No Abstract]   [Full Text] [Related]  

  • 42. On the mechanism of action of 15-methyl-PGF2 alpha as an abortifacient.
    Gréen K; Svanborg K
    Prostaglandins; 1979 Feb; 17(2):277-82. PubMed ID: 441436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extraovular prostaglandin F2 alpha as an abortifacient in early midtrimester pregnancy.
    Robins J; Mitler L; Pollack L; Mann LI
    Adv Plan Parent; 1975; 10(1):39-44. PubMed ID: 1164987
    [No Abstract]   [Full Text] [Related]  

  • 45. Preliminary trials of vaginal silastic devices containing (15s)-15 methyl prostaglandin f2 alpha methyl ester for the induction of menses and for pregnancy termination summary of brook lodge workshop (January 29, 1976).
    Southern EM
    Prostaglandins; 1976; 12 Suppl():147-52. PubMed ID: 788056
    [No Abstract]   [Full Text] [Related]  

  • 46. Double-balloon instillation device for second-trimester abortion. Outcome in 340 consecutive cases.
    Abramovici H; Bornstein J; Ben-David Y; Yishai D; Rofe A; Atad J
    J Reprod Med; 1995 Jan; 40(1):56-62. PubMed ID: 7722978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T; Tabuchi T; Tabei T; Kaku R
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of two dose schedules of 15 (S) 15 methyl PGF2alpha methyl ester vaginal suppositories for dilatation of cervix prior to vacuum aspiration for late first trimester abortions.
    Zoremthangi B; Agarwal N; Puri CP; Laumas KR; Saraya LK; Hingorani V
    Contraception; 1977 Mar; 15(3):285-93. PubMed ID: 880808
    [No Abstract]   [Full Text] [Related]  

  • 49. Outpatient postconceptional fertility control with vaginally administered 15(S) 15-methyl-PGF2alpha-methyl ester.
    Bygdeman M; Martin JN; Eneroth P; Leader A; Lundström V
    Am J Obstet Gynecol; 1976 Mar; 124(5):495-8. PubMed ID: 1258906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abortifacient efficiency of 15 (S) 15-methyl-prostaglandin F2alpha-methyl ester administered vaginally during early pregnancy.
    Ylikorkala O; Järvinen PA; Puukka M; Viinikka L
    Prostaglandins; 1976 Oct; 12(4):609-24. PubMed ID: 973006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical use of prostaglandins for pregnancy termination.
    Bygdeman M; Bergström S
    Popul Rep G; 1976 Sep; (7):65-75. PubMed ID: 791732
    [No Abstract]   [Full Text] [Related]  

  • 52. Early pregnancy interruption with a single PGF2 alpha 15-methyl-analogue vaginal suppository.
    Borten M; Friedman EA
    J Reprod Med; 1985 Oct; 30(10):741-4. PubMed ID: 3877806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Induction of abortion with prostaglandin F2 alpha. Cervix dilatation with 3 mg prostaglandin F2 alpha gel in the 1. trimester. Experiences after 197 induced abortions].
    Knabe H; Lehmann F
    Fortschr Med; 1978 Feb; 96(7):360-2. PubMed ID: 627384
    [No Abstract]   [Full Text] [Related]  

  • 54. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficiency and complication rate of intracervical prostaglandin F2 alpha administration for induced abortion].
    Hölzel D; Berle P
    Arch Gynecol; 1979 Jul; 228(1-4):412-3. PubMed ID: 485399
    [No Abstract]   [Full Text] [Related]  

  • 56. Prostaglandin E2 vaginal suppository as a midtrimester abortifacient.
    Bolognese RJ; Corson SL
    Am J Obstet Gynecol; 1974 Sep; 120(2):281-4. PubMed ID: 4415348
    [No Abstract]   [Full Text] [Related]  

  • 57. Extraamniotic infusion of prostaglandin F2 alpha in normal saline for termination of midtrimester missed abortion.
    Jaschevatzky OE; Leiserowitz DM; Miller M; Grunstein S
    Eur J Obstet Gynecol Reprod Biol; 1983 Jul; 15(3):185-7. PubMed ID: 6578154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experience with the interruption of pregnancy in the Ist and IInd trimester by means of prostaglandin F 2alpha vaginally administered (author's transl)].
    Havránek F; Jungmannová C
    Cesk Gynekol; 1974 Jul; 39(5):368-71. PubMed ID: 4844833
    [No Abstract]   [Full Text] [Related]  

  • 59. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaginal administration of prostaglandins to induce early abortion.
    Hale RW; Pion RJ; Schiner WB
    Adv Biosci; 1973; 9():561-5. PubMed ID: 4805869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.